Your browser doesn't support javascript.
loading
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection]. / Triple terapia 10 días con esomeprazol 40 mg/12 h vs. cuádruple concomitante sin bismuto como tratamiento de primera línea de la infección por Helicobacter pylori.
Campillo, Ana; Amorena, Edurne; Ostiz, Miriam; Kutz, Marcos; LaIglesia, Matilde.
Affiliation
  • Campillo A; Aparato Digestivo, Hospital Reina Sofía, Tudela, Navarra, España. Electronic address: campilloarregui@gmail.com.
  • Amorena E; Aparato Digestivo, Hospital Reina Sofía, Tudela, Navarra, España.
  • Ostiz M; Aparato Digestivo, Hospital Reina Sofía, Tudela, Navarra, España.
  • Kutz M; Aparato Digestivo, Hospital Reina Sofía, Tudela, Navarra, España.
  • LaIglesia M; Aparato Digestivo, Hospital Reina Sofía, Tudela, Navarra, España.
Gastroenterol Hepatol ; 39(9): 584-589, 2016 Nov.
Article in Es | MEDLINE | ID: mdl-27084668

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Helicobacter pylori / Helicobacter Infections / Proton Pump Inhibitors / Esomeprazole / Gastritis Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: Es Journal: Gastroenterol Hepatol Year: 2016 Document type: Article Country of publication: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Helicobacter pylori / Helicobacter Infections / Proton Pump Inhibitors / Esomeprazole / Gastritis Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: Es Journal: Gastroenterol Hepatol Year: 2016 Document type: Article Country of publication: Spain